Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. Phase 1 Clinical trials in the US are underway.
Org chart
Collapse
Teams
This company has no teams yet
Offices
This company has no offices yet
